Literature DB >> 24653793

Hepato-cardiac disorders.

Yasser Mahrous Fouad1, Reem Yehia1.   

Abstract

Understanding the mutual relationship between the liver and the heart is important for both hepatologists and cardiologists. Hepato-cardiac diseases can be classified into heart diseases affecting the liver, liver diseases affecting the heart, and conditions affecting the heart and the liver at the same time. Differential diagnoses of liver injury are extremely important in a cardiologist's clinical practice calling for collaboration between cardiologists and hepatologists due to the many other diseases that can affect the liver and mimic haemodynamic injury. Acute and chronic heart failure may lead to acute ischemic hepatitis or chronic congestive hepatopathy. Treatment in these cases should be directed to the primary heart disease. In patients with advanced liver disease, cirrhotic cardiomyopathy may develop including hemodynamic changes, diastolic and systolic dysfunctions, reduced cardiac performance and electrophysiological abnormalities. Cardiac evaluation is important for patients with liver diseases especially before and after liver transplantation. Liver transplantation may lead to the improvement of all cardiac changes and the reversal of cirrhotic cardiomyopathy. There are systemic diseases that may affect both the liver and the heart concomitantly including congenital, metabolic and inflammatory diseases as well as alcoholism. This review highlights these hepatocardiac diseases.

Entities:  

Keywords:  Cardiac cirrhosis; Fatty liver; Heart failure; Ischemic hepatitis; Liver cirrhosis

Year:  2014        PMID: 24653793      PMCID: PMC3953805          DOI: 10.4254/wjh.v6.i1.41

Source DB:  PubMed          Journal:  World J Hepatol


  133 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

2.  Furosemide absorption in patients with cirrhosis.

Authors:  M J Fredrick; D C Pound; S D Hall; D C Brater
Journal:  Clin Pharmacol Ther       Date:  1991-03       Impact factor: 6.875

Review 3.  Nonalcoholic fatty liver disease and the coronary artery disease.

Authors:  Sombat Treeprasertsuk; Francisco Lopez-Jimenez; Keith D Lindor
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

4.  Pharmacokinetics of valsartan in patients with liver disease.

Authors:  L J Brookman; P E Rolan; I S Benjamin; K R Palmer; P J Wyld; P Lloyd; G Flesch; F Waldmeier; A Sioufi; F Mullins
Journal:  Clin Pharmacol Ther       Date:  1997-09       Impact factor: 6.875

5.  Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis.

Authors:  Peter Schenk; Maximilian Schöniger-Hekele; Valentin Fuhrmann; Christian Madl; Gerd Silberhumer; Christian Müller
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

6.  Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury.

Authors:  W M Cassidy; T B Reynolds
Journal:  J Clin Gastroenterol       Date:  1994-09       Impact factor: 3.062

7.  Influence of left ventricular mass, uremia and hypertension on vagal tachycardic reserve.

Authors:  Luca Mircoli; Rodolfo Rivera; Giuseppe Bonforte; Luigi Fedele; Simonetta Genovesi; Maurizio Surian; Alberto U Ferrari
Journal:  J Hypertens       Date:  2003-08       Impact factor: 4.844

8.  Effects of captopril on renal function in patients with cirrhosis and ascites.

Authors:  G Daskalopoulos; M Pinzani; N Murray; R Hirschberg; R D Zipser
Journal:  J Hepatol       Date:  1987-06       Impact factor: 25.083

9.  Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis).

Authors:  I R Wanless; J J Liu; J Butany
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

10.  Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis.

Authors:  Benjamin Terrier; Alexandre Karras; Philippe Cluzel; Jean-Philippe Collet; Damien Sène; David Saadoun; Patrice Cacoub
Journal:  Am J Cardiol       Date:  2012-10-30       Impact factor: 2.778

View more
  29 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 2.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

3.  Hepatic Encephalopathy in Liver Cirrhosis.

Authors:  Herbert Djiambou-Nganjeu
Journal:  J Transl Int Med       Date:  2017-03-31

Review 4.  Cardiovascular dysfunction in patients with liver cirrhosis.

Authors:  Giuseppe Fede; Graziella Privitera; Tania Tomaselli; Luisa Spadaro; Francesco Purrello
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar

5.  Pulmonary hypertension and cardiac hypertrophy in children recipients of orthotopic living related liver transplantation.

Authors:  Magd A Kotb; Inas Abd El Satar; Ahmed M Badr; Nancy H Anis; Hoda Abd El Rahman Ismail; Alaa F Hamza; Hesham M Abdelkader
Journal:  J Adv Res       Date:  2017-07-27       Impact factor: 10.479

6.  Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Ming Gao; Yi Cheng; Yang Zheng; Weihua Zhang; Lin Wang; Ling Qin
Journal:  BMC Cardiovasc Disord       Date:  2017-01-28       Impact factor: 2.298

7.  Hepatoprotective effects of betaine on liver damages followed by myocardial infarction.

Authors:  Mahsa Hasanzadeh-Moghadam; Mohammad Hassan Khadem-Ansari; Gholam Hossein Farjah; Yousef Rasmi
Journal:  Vet Res Forum       Date:  2018-06-16       Impact factor: 1.054

Review 8.  Peritoneal Dialysis Use in Patients With Ascites: A Review.

Authors:  Nilum Rajora; Lucia De Gregorio; Ramesh Saxena
Journal:  Am J Kidney Dis       Date:  2021-06-16       Impact factor: 8.860

9.  Evaluating of Physiological Chemical Levels in Blood to Assess the Risk of Morbidity and Mortality of Ischemic Cardiovascular Disease.

Authors:  Junyan Teng; Yanping Wei; Fengming Su; Zhiping Guo; Jing-Quan Zhong
Journal:  Int J Environ Res Public Health       Date:  2015-09-14       Impact factor: 3.390

10.  Complications related to intraoperative transesophageal echocardiography in liver transplantation.

Authors:  Sher-Lu Pai; Stephen Aniskevich; Neil G Feinglass; Beth L Ladlie; Claudia C Crawford; Prith Peiris; Klaus D Torp; Timothy S Shine
Journal:  Springerplus       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.